Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Capital Expenditure

-₹25.85B

TTM · Period ending: · INR

RDY logo

RDY Capital Expenditure

Latest reported-₹25.85B INR
RDY TTM CapEx · INR (-₹1.44B → -₹25.85B)
High-resolution chart · PNG

RDY capital expenditure history

Trailing twelve months (TTM) · INR. Each value covers four complete reported quarters.

Dr. Reddy's Laboratories Ltd Common Stock Capital Expenditure — Trailing twelve months (TTM) (INR)
Period endingCapital Expenditure (INR)
-25,845,826,000
-32,290,826,000
-38,848,000,000
-40,347,000,000
-38,121,000,000
-34,398,000,000
-23,215,288,454
-14,442,325,960
-10,472,325,960
-16,219,325,960
-19,902,037,506
-22,955,000,000
-22,345,000,000
-18,864,000,000
-19,145,000,000
-20,520,000,000
-24,402,000,000
-19,049,000,000
-15,061,842,380
-10,626,777,917
-6,090,777,917
-4,644,777,917
-4,616,499,033
-5,957,563,496
-4,481,563,496
-4,029,563,496
-5,335,000,000
-5,685,000,000
-6,623,000,000
-7,491,000,000
-7,821,000,000
-9,431,000,000
-10,291,000,000
-11,043,000,000
-12,748,000,000
-12,506,000,000
-36,246,000,000
-40,984,000,000
-41,192,000,000
-42,931,000,000
-19,863,000,000
-14,875,000,000
-14,054,000,000
-17,217,000,000
-15,906,000,000
-15,327,000,000
-14,670,000,000
-9,317,000,000
-10,765,000,000
-10,627,000,000
-10,586,000,000
-9,578,000,000
-7,524,000,000
-7,336,000,000
-7,126,000,000
-6,957,000,000
-7,060,000,000
-8,585,000,000
-9,093,000,000
-12,926,000,000
-13,138,000,000
-11,606,000,000
-11,196,000,000
-6,378,000,000
-5,723,000,000
-4,283,000,000
-3,071,000,000
-3,811,038,000
-3,816,406,000
-4,761,000,000
-6,558,960,093
-7,081,559,277
-7,144,849,437
-6,769,600,000
-5,606,466,307
-5,124,346,403
-4,689,226,307
-4,747,612,771
-4,704,566,611
-3,381,563,739
-2,709,697,177
-1,919,748,753
-1,162,399,622
-1,571,477,524
-1,579,079,269
-1,749,170,215
-1,827,191,393
-2,104,451,671
-2,434,532,019
-2,420,867,794
-2,243,317,670
-1,967,174,185
-1,647,091,827
-1,511,374,569
-1,439,317,345
-1,356,620,938
-1,273,940,110
-1,089,146,128
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.